GSK GlaxoSmithKline PLC ADR

USD 33.78 +0.35 ( +1.05%)
Icon

GlaxoSmithKline PLC ADR (GSK) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 33.78

+0.35 (+1.05%)

N/A

4.11M

USD 42.25(+25.07%)

USD 44.00 (+30.25%)

Icon

GSK

GlaxoSmithKline PLC ADR (USD)
COMMON STOCK | NYE
USD 33.78
+0.35 ( +1.05%)

GlaxoSmithKline PLC ADR (GSK) Stock Forecast

USD 42.25
(+25.07%)

Based on the GlaxoSmithKline PLC ADR stock forecast from 2 analysts, the average analyst target price for GlaxoSmithKline PLC ADR is USD 42.25 over the next 12 months. GlaxoSmithKline PLC ADR’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC ADR is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, GlaxoSmithKline PLC ADR’s stock price was USD 33.78. GlaxoSmithKline PLC ADR’s stock price has changed by +5.30% over the past week, +0.54% over the past month and -14.87% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...